Insider Transactions in Q3 2022 at Celldex Therapeutics, Inc. (CLDX)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Aug 18
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
1,355
-51.35%
|
$48,780
$36.38 P/Share
|
|
Aug 18
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
1,355
+33.93%
|
$12,195
$9.02 P/Share
|
|
Aug 17
2022
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
64,000
+48.11%
|
$384,000
$6.55 P/Share
|
|
Aug 17
2022
|
Diane C. Young SVP, CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct |
19,000
-89.98%
|
$703,000
$37.3 P/Share
|
|
Aug 17
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
SELL
Open market or private sale
|
Direct |
31,312
-96.06%
|
$1,127,232
$36.73 P/Share
|
|
Aug 17
2022
|
Sarah Cavanaugh SVP OF CORP AFFAIRS & ADMIN. |
BUY
Exercise of conversion of derivative security
|
Direct |
31,312
+49.0%
|
$62,624
$2.78 P/Share
|
|
Aug 15
2022
|
Anthony S Marucci PRESIDENT & CEO |
SELL
Open market or private sale
|
Direct |
120,000
-81.25%
|
$4,440,000
$37.66 P/Share
|
|
Aug 15
2022
|
Anthony S Marucci PRESIDENT & CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
120,000
+32.78%
|
$600,000
$5.9 P/Share
|
|
Aug 15
2022
|
Richard M. Wright SR. VP & CCO |
SELL
Open market or private sale
|
Direct |
15,328
-98.66%
|
$567,136
$37.71 P/Share
|
|
Aug 15
2022
|
Richard M. Wright SR. VP & CCO |
BUY
Exercise of conversion of derivative security
|
Direct |
15,328
+49.66%
|
$153,280
$10.38 P/Share
|
|
Aug 12
2022
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
17,547
-15.42%
|
$614,145
$35.59 P/Share
|
|
Aug 12
2022
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
17,547
+18.33%
|
$87,735
$5.9 P/Share
|
|
Aug 11
2022
|
Samuel Bates Martin SVP AND CFO |
SELL
Open market or private sale
|
Direct |
2,453
-9.14%
|
$90,761
$37.04 P/Share
|
|
Aug 11
2022
|
Samuel Bates Martin SVP AND CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
2,453
+8.38%
|
$22,077
$9.02 P/Share
|